Bill Text: CA SB1390 | 2009-2010 | Regular Session | Introduced
NOTE: There are more recent revisions of this legislation. Read Latest Draft
Bill Title: Prescription drug labels.
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Engrossed - Dead) 2010-06-29 - Set, first hearing. Failed passage in committee. [SB1390 Detail]
Download: California-2009-SB1390-Introduced.html
Bill Title: Prescription drug labels.
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Engrossed - Dead) 2010-06-29 - Set, first hearing. Failed passage in committee. [SB1390 Detail]
Download: California-2009-SB1390-Introduced.html
BILL NUMBER: SB 1390 INTRODUCED BILL TEXT INTRODUCED BY Senator Corbett FEBRUARY 19, 2010 An act to amend Section 4076.5 of the Business and Professions Code, relating to pharmacy. LEGISLATIVE COUNSEL'S DIGEST SB 1390, as introduced, Corbett. Prescription drug labels. Existing law, the Pharmacy Law, provides for the licensure and regulation of the practice of pharmacy by the California State Board of Pharmacy. Existing law requires the board to promulgate regulations that require, on or before January 1, 2011, a standardized, patient-centered, prescription drug label on all prescription medication dispensed to patients in California. This bill would authorize the board to exempt certain prescriptions dispensed to patients in a long-term care facility from these regulatory requirements. Vote: majority. Appropriation: no. Fiscal committee: yes. State-mandated local program: no. THE PEOPLE OF THE STATE OF CALIFORNIA DO ENACT AS FOLLOWS: SECTION 1. Section 4076.5 of the Business and Professions Code is amended to read: 4076.5. (a) The board shall promulgate regulations that require, on or before January 1, 2011, a standardized, patient-centered, prescription drug label on all prescription medicine dispensed to patients in California. (b) To ensure maximum public comment, the board shall hold public meetings statewide that are separate from its normally scheduled hearings in order to seek information from groups representing consumers, seniors, pharmacists or the practice of pharmacy, other health care professionals, and other interested parties. (c) When developing the requirements for prescription drug labels, the board shall consider all of the following factors: (1) Medical literacy research that points to increased understandability of labels. (2) Improved directions for use. (3) Improved font types and sizes. (4) Placement of information that is patient-centered. (5) The needs of patients with limited English proficiency. (6) The needs of senior citizens. (7) Technology requirements necessary to implement the standards. (d) The board may exempt certain prescriptions dispensed to patients in a long-term care facility from the requirements of the regulations promulgated pursuant to subdivision (a).(d)(e) (1) On or before January 1, 2010, the board shall report to the Legislature on its progress under this section as of the time of the report. (2) On or before January 1, 2013, the board shall report to the Legislature the status of implementation of the prescription drug label requirements adopted pursuant to this section.